Akoustis Technologies (AKTSQ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for November 21, 2024, with voting available online or virtually.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of six directors: Kamran S. Cheema, Steven P. DenBaars, Jill K. Frizzley, Arthur E. Geiss, Matthew R. Kahn, and Jerry D. Neal.
Advisory vote on executive compensation for named executive officers.
Proposal to approve amendments for a reverse stock split at ratios between 1-for-50 and 1-for-250, with the final ratio to be selected by the board within one year.
Ratification of Marcum LLP as independent registered public accounting firm for fiscal year ending June 30, 2025.
Proxies may vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals and director nominees.
Latest events from Akoustis Technologies
- Key votes include director elections, executive pay, a reverse stock split, and auditor ratification.AKTSQ
Proxy Filing1 Dec 2025 - Key votes include director elections, a reverse stock split, and auditor ratification.AKTSQ
Proxy Filing1 Dec 2025 - Annual Meeting adjourned for lack of quorum; voting extended to December 12, 2024.AKTSQ
Proxy Filing1 Dec 2025 - Annual meeting adjourned for lack of quorum; voting extended to January 9, 2025.AKTSQ
Proxy Filing1 Dec 2025 - Shareholders to vote on a reverse split as Nasdaq grants conditional continued listing.AKTSQ
Proxy Filing1 Dec 2025 - Kingsdale was engaged to assist with proxy solicitation for the 2024 annual meeting.AKTSQ
Proxy Filing1 Dec 2025 - Severe litigation losses and asset impairments drove Akoustis to a $167.9M net loss and liquidity crisis.AKTSQ
Q4 202413 Jun 2025 - Litigation-driven liquidity crisis threatens Akoustis' survival despite improved operating results.AKTSQ
Q1 202513 Jun 2025